What are the treatments for whooping cough?;Quel traitement pour la coqueluche?

Medecine Therapeutique Pediatrie

Volumn 9, Issue 3, 2006, Pages 170-174

  Floret, Daniel ^a  

^a UNIVERSITÉ LYON 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; AZITHROMYCIN; CLARITHROMYCIN; CORTICOSTEROID; COTRIMOXAZOLE; DIPHENHYDRAMINE; ERYTHROMYCIN; IMMUNOGLOBULIN; JOSAMYCIN; PLACEBO; SALBUTAMOL;

ANTIBIOTIC THERAPY; HUMAN; HYPERTENSION; INCIDENCE; PERTUSSIS; REVIEW; THROMBOCYTOSIS; VACCINATION;

EID: 33749574523     PISSN: 12865494     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Tan T, Trindade E, Skowronski D. Epidemiology of pertussis. Pediatr Infect Dis J 2005; 24(Supplement): S10-S17.
2. Floret D. Groupe de Pathologie Infectieuse Pédiatrique, Groupe Francophone de Réanimation et Urgence Pédiatrique. Les décès par infection bactérienne communautaire. Enquête dans les services de réanimation pédiatrique français. Arch Pediatr 2001; 8(Suppl 4): 705s-11s.
3. Wirsing von König. Use of antibiotics in the prevention and treatment of pertussis. Pediatr Infect Dis J 2005; 24 Supplement): S66-8.
4. Berquist S, Bernander S, Dahnsjo H, Sundelof B. Erythromycin in the treatment of pertussis: a study of bacteriologic and clinical effect. Pediatr Infect Dis J 1987; 6: 458-61.
5. Altunaiji S, Kukuruzovic R, Curtis N, Massie J. Antibiotics for wooping cough (pertussis) (Review). The Cochrane Library 2005; 4: 1-45.
6. Rapport du Conseil Supérieur d'Hygiène Publique de France section maladies transmissibles relatif à la conduite à tenir devant un ou plusieurs cas de coqueluche. Validation 16 janvier 2004. www.sante.gouv.fr.
7. Floret D, Bonmarin I, Deutsch P, et al. Conduite à tenir devant un ou plusieurs cas de coqueluche. Arch Pediatr 2005; 12: 1281-91.
8. Halperin SA, Bortolussi R, Langley JM, Miller B, Eastwood BJ. Seven days of erythromycin estolate is as effective as fourteen days for the treatment of Bordetella pertussis infections. Pediatrics 1997; 100: 65-71.
9. Hope JE. State of the art in antibacterial susceptibility of Bordetella pertussis and antibiotic treatment of pertussis. Infection 1998; 26: 242-6.
10. Hope JE, Erythromycin Study Group. Comparaison of erythromycin estolate and erythromycin ethylsuccinate for treatment of pertussis. Pediatr Infect Dis J 1992; 11: 189-93.
11. Honein MA, Paulozzi LJ, Himelright IM, et al. Infantile hypertrophic pyloric stenosis after pertussis prophylaxis with erythromycin: a case review and cohort study. Lancet 1999; 353: 18-25.
12. Anonyme. In: Hypertrophic Pyloric Stenosis in Infants Following Pertussis Prophylaxis with Erythromycin. Knoxville: Tenesse, 1999: 1117-20; (MMWR).
13. Torre D, Maggiolo F, Sampietro C. Comparative clinical study of josamycin and erythromycin in pertussis. Chemioterapia 1984; 3: 255-7.
14. Lebel MH, Mehra S. Efficacy and safety of clarithromycin versus erythromycin for the treatment of pertussis: a prospective, randomized, single blind trial. Pediatr Infect Dis J 2001; 20: 1149-54.
15. Pichichero ME, Hoeger WJ, Casey JR. Azithromycin for the treatment of pertussis. Pediatr Infect Dis J 2003; 22: 847-9.
16. Hope JE, Halm U, Hagedorn HJ, et al. Comparaison of erythromycin ethylsuccinate and cotrimoxazole for treatment of pertussis. Infection 1989; 17: 227-31.
17. American Academy of Pediatrics. Red Book. In: Pickering LK, ed. Report of the Committee on Infectious Diseases. 26th ed. Elk Grove Village II, 2003.
18. Tozzi AE, Pastore Celentano L. Ciofi degli Atti ML, Salmaso S. Diagnosis and management of pertussis. CMAJ 2005; 172: 509-15.
19. Bace A, Kuzmanovic N, Novak D, et al. The efficacy and safety of 3-day azithromycin vs 14-day erythromycin in the treatment of pertussis in infants and young children. Italy: ICMASKO 6 Bologna, 2002; (January).
20. Danzon A, Lacroix J, Infante-Rivard C, Chicoine L. A double-blind clinical trial on diphenylhydramine. Acta Paediatr Scand 1988; 77: 614-5.
21. Zoumboulakis D, Anagnostakis D, Albanis V, Matsanioitis N. Steroids in treatment of pertussis. A controlled clinical trial. Arch Dis Child 1973; 48: 51-4.
22. Roberts I, Gavin R, Lennon D. A randomized trial of steroids in treatment of pertussis. Pediatr Infect Dis J 1992; 11: 982-3.
23. Krantz I, Norrby SR, Trolfors B. Salbutamol vs placebo for treatment of pertussis. Pediatr Infect Dis J 1985; 4: 638-40.
24. Mertsola J, Viljanen MK, Ruuskanen O. Salbutamol in the treatment of whooping cough. Scand J Infect Dis 1986; 18: 593-4.
25. Granstrom M, Olinder-Nielsen AM, Holmbard P, Mark A, Hangren K. Specific immunoglobulin for treatment of whooping cough. Lancet 1991; 338: 1230-3.
26. Pillay V, Swingler G. Symptomatic treatment of the cough in whooping cough (Review). The Cochrane Library 2005; 4: 1-15.
27. Irwin RS, Madison JM. The diagnosis and treatment of cough. N Engl J Med 2000; 343: 1715-21.
28. RENACOQ. Principales caractéristiques des cas de coqueluche identifies par le réseau Renacoq, 1996-2004. www.invs.sante.fr/recherche/ index2.asp?txtQuery=RENACOQ.
29. Mikelova LK, Halperin SA, Schiefele D, et al. Predictors of death in infant hospitalized with pertussis: a case-control study of 16 pertussis deaths in Canada. J Pediatr 2003; 143: 576-81.
30. Bruss JB, Malley R, Halperin S, et al. Treatment of severe pertussis: a study of the safety and pharmacology of intravenous pertussis immunoglobulin. Pediatr Infect Dis J 1999; 18: 505-11.
31. Guillois B. Groupe Francophone de Reanimation et Urgence Pédiatrique. Aspects épidémiologiques et cliniques des coqueluches graves hospitalisées en réanimation de 1990 à 1994. Med Mal Infect 1995: 1272-80; (25 Spécial).
32. Goulin GD, Kaya KM, Bradley Y. Severe pulmonary hypertension associated with shock and death in infants infected with Bordetella pertussis. Crit Care Med 1993; 21: 1791-3.
33. Casano P, Pons Odena M, Cambra JF, Martin JM, Palomeque A. Bordetella pertussis infection causing pulmonary hypertension. Arch Dis Child 2002; 86: 453-4.
34. Skladal D, Horak E, Fruhwirth M, Maurer H, Simma B. Successful treatment of ARDS and severe pulmonary hypertension in a child with Bordetella pertussis infection. Wien Klin Wochenschr 2004; 116: 760-2.
35. Smith C, Vyas H. Early infantile pertussis; increasingly prevalent and potentially fatal. Eur J Pediatr 2000; 159: 898-900.
36. Pooboni S, Roberts N, Westrope C, et al. Extracorporeal life support in pertussis. Pediatr Pulmonol 2003; 36: 310-5.
37. Romano MJ, Weber MD, Weisse ME, Siu BL. Pertussis pneumonia, hypoxemia, hyperleukocytosis, and pulmonary hypertension: improvement in oxygenation after a double volume exchange transfusion. Pediatrics 2004; 114: 264-6.